{"id":"https://openalex.org/W2137646375","doi":"https://doi.org/10.2165/00019053-200321050-00004","title":"Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer??s Disease","display_name":"Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer??s Disease","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2137646375","doi":"https://doi.org/10.2165/00019053-200321050-00004","mag":"2137646375","pmid":"https://pubmed.ncbi.nlm.nih.gov/12627986"},"language":"en","primary_location":{"id":"doi:10.2165/00019053-200321050-00004","doi":"https://doi.org/10.2165/00019053-200321050-00004","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00019053-200321050-00004","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2137646375"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087161178","display_name":"Anders B. Wimo","orcid":"https://orcid.org/0000-0003-0963-5750","observed_orcids":["https://orcid.org/0000-0003-0963-5750"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anders Wimo","raw_affiliation_strings":["Division of Geriatric Epidemiology (Sector of Health Economy), Neurotec, Karolinska Institute, Huddinge, Sweden. Anders.Wimo@telia.com","Division of Geriatric Epidemiology (Sector of Health Economy), Neurotec, Karolinska Institute, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Geriatric Epidemiology (Sector of Health Economy), Neurotec, Karolinska Institute, Huddinge, Sweden. Anders.Wimo@telia.com","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Division of Geriatric Epidemiology (Sector of Health Economy), Neurotec, Karolinska Institute, Huddinge, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081283156","display_name":"Bengt G. Winblad","orcid":"https://orcid.org/0000-0002-0011-1179","observed_orcids":["https://orcid.org/0000-0002-0011-1179"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bengt Winblad","raw_affiliation_strings":["Division of Geriatric Epidemiology, Neurotec, Karolinska Institute, Huddinge, Sweden","Karolinska Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Geriatric Epidemiology, Neurotec, Karolinska Institute, Huddinge, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Karolinska Inst","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011412905","display_name":"Albrecht St\u00f6ffler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113494","display_name":"Merz (Germany)","ror":"https://ror.org/025f1e779","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210113494"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Albrecht Stoffler","raw_affiliation_strings":["Merz Pharmaceuticals GmbH, Frankfurt/Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merz Pharmaceuticals GmbH, Frankfurt/Main, Germany","institution_ids":["https://openalex.org/I4210113494"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016091756","display_name":"Yvonne Wirth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113494","display_name":"Merz (Germany)","ror":"https://ror.org/025f1e779","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210113494"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yvonne Wirth","raw_affiliation_strings":["Merz Pharmaceuticals GmbH, Frankfurt/Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merz Pharmaceuticals GmbH, Frankfurt/Main, Germany","institution_ids":["https://openalex.org/I4210113494"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002356360","display_name":"Hans J. Moebius","orcid":"https://orcid.org/0000-0002-6311-0157","observed_orcids":["https://orcid.org/0000-0002-6311-0157"]},"institutions":[{"id":"https://openalex.org/I4210113494","display_name":"Merz (Germany)","ror":"https://ror.org/025f1e779","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210113494"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hansjorg Mobius","raw_affiliation_strings":["Merz Pharmaceuticals GmbH, Frankfurt/Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merz Pharmaceuticals GmbH, Frankfurt/Main, Germany","institution_ids":["https://openalex.org/I4210113494"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5087161178"],"corresponding_institution_ids":["https://openalex.org/I28166907"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":10.3209,"has_fulltext":false,"cited_by_count":178,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98810717,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"21","issue":"5","first_page":"327","last_page":"340"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8090999722480774,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8090999722480774,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.1543000042438507,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.02889999933540821,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":0.7929999828338623},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":1.0},{"id":"https://openalex.org/keywords/resource-utilization-health-care","display_name":"resource utilization (health care)","score":0.8230000138282776},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.7870000004768372},{"id":"https://openalex.org/keywords/caregiver-burden","display_name":"caregiver burden","score":0.8519999980926514},{"id":"https://openalex.org/keywords/institutionalization","display_name":"institutionalization","score":0.878000020980835},{"id":"https://openalex.org/keywords/social-costs","display_name":"social costs","score":0.3799999952316284},{"id":"https://openalex.org/keywords/moderate-to-severe-dementia","display_name":"moderate to severe dementia","score":0.6710000038146973},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.7670000195503235},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.40299999713897705},{"id":"https://openalex.org/keywords/non-medical-costs","display_name":"non-medical costs","score":0.5839999914169312},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.4269999861717224},{"id":"https://openalex.org/keywords/residential-status","display_name":"residential status","score":0.6389999985694885},{"id":"https://openalex.org/keywords/caregiver-costs","display_name":"caregiver costs","score":0.6890000104904175}],"concepts":[{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.8276090621948242},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6498878598213196},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.49908995628356934},{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.4149560332298279},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.413211464881897},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.4085606336593628},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.33060479164123535},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2998330295085907},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28324633836746216},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.07361316680908203},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000203","descriptor_name":"Activities of Daily Living","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006295","descriptor_name":"Health Resources","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008559","descriptor_name":"Memantine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D008559","descriptor_name":"Memantine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017028","descriptor_name":"Caregivers","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2165/00019053-200321050-00004","doi":"https://doi.org/10.2165/00019053-200321050-00004","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00019053-200321050-00004","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmid:12627986","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12627986","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Clinical Trial"},{"id":"pmh:oai:RePEc:wkh:phecon:v:21:y:2003:i:5:p:327-340","doi":null,"is_oa":false,"landing_page_url":"http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200321050-00004.htm","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320327810","display_name":"Merz Pharmaceuticals","ror":"https://ror.org/025f1e779"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W38490725","https://openalex.org/W51869439","https://openalex.org/W1512398135","https://openalex.org/W1644143258","https://openalex.org/W1847168837","https://openalex.org/W1904871314","https://openalex.org/W1963905681","https://openalex.org/W1965139921","https://openalex.org/W1965360119","https://openalex.org/W1973900812","https://openalex.org/W1974269419","https://openalex.org/W1975975999","https://openalex.org/W1993788242","https://openalex.org/W1994694744","https://openalex.org/W1996776294","https://openalex.org/W2004362520","https://openalex.org/W2008854521","https://openalex.org/W2013239352","https://openalex.org/W2015400724","https://openalex.org/W2022866546","https://openalex.org/W2025115831","https://openalex.org/W2030079540","https://openalex.org/W2037392579","https://openalex.org/W2039585634","https://openalex.org/W2044319194","https://openalex.org/W2056117185","https://openalex.org/W2066734262","https://openalex.org/W2110951376","https://openalex.org/W2133958927","https://openalex.org/W2148080316","https://openalex.org/W2148796274","https://openalex.org/W2152681246","https://openalex.org/W2156220037","https://openalex.org/W2159011576","https://openalex.org/W2162321627","https://openalex.org/W2167311298","https://openalex.org/W2170085655","https://openalex.org/W2297722685","https://openalex.org/W2474469682","https://openalex.org/W2775750683"],"related_works":["https://openalex.org/W1986658783","https://openalex.org/W1494495319","https://openalex.org/W1661354326","https://openalex.org/W1973730432","https://openalex.org/W1976868978","https://openalex.org/W2554314920","https://openalex.org/W2146970300","https://openalex.org/W1975743278","https://openalex.org/W2016566279","https://openalex.org/W2090987295"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2137646375","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
